Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-9.40	130.05	143.54
Graham Fair Price	41.47	0.13	0.09
PEG	47.39	1.05	-0.71
Price/Book	211.75	2.74	0.88
Price/Cash Flow	14.02	-230.00	-267.50
Prices/Earnings	55.88	105.08	67.41
Price/Sales	55.88	1.60	1.02
Price/FCF	14.02	-230.00	-267.50
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-5.95	0.10	0.11
Operating Margin	0.00	< 0.005	< 0.005
ROA	100.00	< 0.005	< 0.005
ROE	< 0.005	< 0.005	100.00
ROIC	< 0.005	< 0.005	98.17
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.04	-0.01	197.02
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.92	1.00	8.79
EPS QOQ	-0.95	1.00	5.76
FCF QOQ	0.96	-2.63	172.52
Revenue QOQ	-0.48	1.00	108.21
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	10.27	5.10	-50.35
Days Sales Outstanding (DSO)	198.45	95.20	-52.03
Inventory Turnover	8.76	17.65	101.42
Debt/Capitalization	0.25	0.26	2.76
Quick Ratio	1.42	1.36	-3.93
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.34	0.34	0.04
Cash	0.02	0.02	0.04
Capex	< 0.005	< 0.005	-100.07
Free Cash Flow	< 0.005	< 0.005	-262.71
Revenue	0.29	0.58	100.07
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.65	1.65	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	33.85	12.20	-63.97
Naive Interpretation	Member

06 - Financial Health · Weak

Rating